Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morgan

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Sexually Transmitted Diseases|May 26, 2025
Bacterial vaginosis incidence following a single hyperosmolal vaginal lubricant exposure: A comparison of two observational cohortsSarah E Brown, Xin He, Laurence Magder, et al.
The Journal of Infectious Diseases|August 31, 2018
A Th2-Type Response Is Associated With Exuberant Lesions in Pregnant Women Infected With Leishmania braziliensisWalderez O Dutra, Daniela Faria Barbosa, Paulo Eduardo Alencar de Souza, et al.
Archives of Sexual Behavior|April 29, 2024
Risk Compensation After Initiation of Daily Oral Pre-exposure Prophylaxis Among Sexual and Gender Minorities in NigeriaOlusegun A Adeyemi, Rebecca G Nowak, Daniel Morgan, et al.
Sexually Transmitted Diseases|March 14, 2025
Prevalence of Amsel-defined bacterial vaginosis before and after transvaginal ultrasound with lubricant applicationSarah E Brown, Xin He, Laurence Magder, et al.
British Journal of Pharmacology|April 15, 2014
Long-term consequences of perinatal fatty acid amino hydrolase inhibitionChia-Shan Wu, Daniel Morgan, Chris P Jew, et al.
American Journal of Obstetrics and Gynecology|December 18, 2024
Assessment of the vaginal microbiota before and after use of hyperosmolal lubricant during transvaginal ultrasoundSarah E Brown, Xin He, Laurence Magder, et al.
Plos One|March 17, 2023
Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in NigeriaOlusegun A Adeyemi, Rebecca G Nowak, Mark Marzinke, et al.
AJNR. American Journal of Neuroradiology|January 9, 2025
Circle of Willis Variants and Their Association with Outcome after Successful Revascularization of Anterior Large Vessel OcclusionAakanksha Sriwastwa, Michael K Oswald, Achala S Vagal, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2016
Development of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonistsMatthew D Hill, Haiquan Fang, Sivarao V Digavalli, et al.
Journal of Medicinal Chemistry|February 24, 2012
Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment 6. Preclinical and human pharmacokinetic profiling of BMS-663749, a phosphonooxymethyl prodrug of the HIV-1 attachment inhibitor 2-(4-benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)John F Kadow, Yasutsugu Ueda, Nicholas A Meanwell, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Sexually Transmitted Diseases|May 26, 2025
Bacterial vaginosis incidence following a single hyperosmolal vaginal lubricant exposure: A comparison of two observational cohortsSarah E Brown, Xin He, Laurence Magder, et al.
The Journal of Infectious Diseases|August 31, 2018
A Th2-Type Response Is Associated With Exuberant Lesions in Pregnant Women Infected With Leishmania braziliensisWalderez O Dutra, Daniela Faria Barbosa, Paulo Eduardo Alencar de Souza, et al.
Archives of Sexual Behavior|April 29, 2024
Risk Compensation After Initiation of Daily Oral Pre-exposure Prophylaxis Among Sexual and Gender Minorities in NigeriaOlusegun A Adeyemi, Rebecca G Nowak, Daniel Morgan, et al.
Sexually Transmitted Diseases|March 14, 2025
Prevalence of Amsel-defined bacterial vaginosis before and after transvaginal ultrasound with lubricant applicationSarah E Brown, Xin He, Laurence Magder, et al.
British Journal of Pharmacology|April 15, 2014
Long-term consequences of perinatal fatty acid amino hydrolase inhibitionChia-Shan Wu, Daniel Morgan, Chris P Jew, et al.
American Journal of Obstetrics and Gynecology|December 18, 2024
Assessment of the vaginal microbiota before and after use of hyperosmolal lubricant during transvaginal ultrasoundSarah E Brown, Xin He, Laurence Magder, et al.
Plos One|March 17, 2023
Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in NigeriaOlusegun A Adeyemi, Rebecca G Nowak, Mark Marzinke, et al.
AJNR. American Journal of Neuroradiology|January 9, 2025
Circle of Willis Variants and Their Association with Outcome after Successful Revascularization of Anterior Large Vessel OcclusionAakanksha Sriwastwa, Michael K Oswald, Achala S Vagal, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2016
Development of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonistsMatthew D Hill, Haiquan Fang, Sivarao V Digavalli, et al.
Journal of Medicinal Chemistry|February 24, 2012
Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment 6. Preclinical and human pharmacokinetic profiling of BMS-663749, a phosphonooxymethyl prodrug of the HIV-1 attachment inhibitor 2-(4-benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)John F Kadow, Yasutsugu Ueda, Nicholas A Meanwell, et al.
Pageof 6